Behavioral factors associated with SARS‐CoV‐2 infection in Japan-Reference-Cited by-同舟云学术

Behavioral factors associated with SARS‐CoV‐2 infection in Japan

Published:2022-04-26 Issue:5 Volume:16 Page:952-961
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Resp Viruses

Author:

Arashiro Takeshi¹²³⁴^ORCID,Arima Yuzo¹,Muraoka Hirokazu⁵,Sato Akihiro⁶,Oba Kunihiro⁷,Uehara Yuki⁸,Arioka Hiroko⁹,Yanai Hideki¹⁰,Yanagisawa Naoki¹¹,Nagura Yoshito¹²,Kato Yasuyuki¹³,Kato Hideaki¹⁴,Ueda Akihiro¹⁵,Ishii Koji¹⁶,Ooki Takao¹⁶,Oka Hideaki¹⁷,Nishida Yusuke¹⁷,Stucky Ashley¹,Miyahara Reiko¹,Smith Chris³⁴,Hibberd Martin³,Ariyoshi Koya⁴,Suzuki Motoi¹

Affiliation:

1. Center for Surveillance, Immunization, and Epidemiologic Research National Institute of Infectious Diseases Tokyo Japan

2. Department of Pathology National Institute of Infectious Diseases Tokyo Japan

3. Faculty of Infectious and Tropical Diseases London School of Hygiene and Tropical Medicine London UK

4. School of Tropical Medicine and Global Health Nagasaki University Nagasaki Japan

5. CLINIC FOR Tamachi Tokyo Japan

6. KARADA Internal Medicine Clinic Tokyo Japan

7. Department of Pediatrics Showa General Hospital Tokyo Japan

8. Department of Clinical Laboratory St. Luke's International Hospital Tokyo Japan

9. Department of General Internal Medicine St. Luke's International Hospital Tokyo Japan

10. Department of Clinical Laboratory, Fukujuji Hospital Japan Anti‐Tuberculosis Association Kiyose Japan

11. Yanagisawa Clinic Tokyo Japan

12. Shinjuku Home Clinic Tokyo Japan

13. Department of Infectious Diseases, Graduate School of Medicine International University of Health and Welfare Chiba Japan

14. Infection Prevention and Control Department Yokohama City University Hospital Yokohama Japan

15. Department of Infectious Diseases Japanese Red Cross Medical Center Tokyo Japan

16. Saitama Sekishinkai Hospital Saitama Japan

17. Department of General Internal Medicine and Infectious Diseases Saitama Medical Center Saitama Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12992

Reference22 articles.

1. World Health Organization.Coronavirus disease (COVID‐19) pandemic.2021. Accessed April 4 2022.https://www.who.int/emergencies/diseases/novel-coronavirus-2019

2. National Institute of Infectious Diseases.Active case investigation on COVID‐19 cases (In Japanese).2021. Accessed April 4 2022.https://www.niid.go.jp/niid/ja/2019-ncov/2559-cfeir/10800-covid19-02.html

3. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan

4. Cabinet Secretariat Government of Japan.COVID‐19 information and resources: measures to be taken based on the basic response policy.2020. Accessed April 4 2022.https://corona.go.jp/en/emergency/

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between beverage consumption and droplet production during respiratory activity using interferometric Mie imaging experiment;Journal of Aerosol Science;2024-11

2. Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020–2022;BMC Public Health;2024-09-04

3. Symptomatic COVID-19 in University Students: A School-Wide Web-Based Questionnaire Survey during the Omicron Variant Outbreak;Advances in Infectious Diseases;2024

4. Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan;Vaccine;2023-11

5. Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan;Open Forum Infectious Diseases;2023-05-03